相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies
Paul Oster et al.
GUT (2022)
Integrative analysis of gut microbiome and host transcriptomes reveals associations between treatment outcomes and immunotherapy-induced colitis
Toshiharu Sakurai et al.
MOLECULAR ONCOLOGY (2022)
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
John A. McCulloch et al.
NATURE MEDICINE (2022)
The effect of taxonomic classification by full-length 16S rRNA sequencing with a synthetic long-read technology
Jinuk Jeong et al.
SCIENTIFIC REPORTS (2021)
A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors
Fyza Y. Shaikh et al.
CLINICAL CANCER RESEARCH (2021)
Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3
Francesco Beghini et al.
ELIFE (2021)
An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma
Ying-Chun Shen et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)
The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
Huihui Yin et al.
CANCER BIOLOGY & MEDICINE (2021)
Physiologic colonic uptake of 18F-FDG on PET/CT is associated with clinical response and gut microbiome composition in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
Lena Cvetkovic et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Gut microbial species and metabolic pathways associated with response to treatment with immune checkpoint inhibitors in metastatic melanoma
Thijs T. Wind et al.
MELANOMA RESEARCH (2020)
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
Lisa Derosa et al.
EUROPEAN UROLOGY (2020)
Predictable modulation of cancer treatment outcomes by the gut microbiota
Yoshitaro Heshiki et al.
MICROBIOME (2020)
Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients
Peng Song et al.
THORACIC CANCER (2020)
Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti-PD-1 Immune Checkpoint Inhibitors
Nicholas J. Salgia et al.
EUROPEAN UROLOGY (2020)
Characterization of gut microbiota in patients with primary hepatocellular carcinoma received immune checkpoint inhibitors A Chinese population-based study
Lili Li et al.
MEDICINE (2020)
The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer
Zhi Peng et al.
CANCER IMMUNOLOGY RESEARCH (2020)
The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer
Taiki Hakozaki et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma
Angelo Limeta et al.
JCI INSIGHT (2020)
Variable selection in microbiome compositional data analysis
Antoni Susin et al.
NAR GENOMICS AND BIOINFORMATICS (2020)
Host variables confound gut microbiota studies of human disease
Ivan Vujkovic-Cvijin et al.
NATURE (2020)
Genomic correlates of response to immune checkpoint blockade
Tanya E. Keenan et al.
NATURE MEDICINE (2019)
The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC
Yueping Jin et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with updates hepatocellular carcinoma
Yi Zheng et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis
Jethro S. Johnson et al.
NATURE COMMUNICATIONS (2019)
Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients
Brandilyn A. Peters et al.
GENOME MEDICINE (2019)
Microbiota and cancer immunotherapy: in search of microbial signals
Raad Z. Gharaibeh et al.
GUT (2019)
Immune correlates of clinical outcome in melanoma
Graham Pawelec
IMMUNOLOGY (2018)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
L. Derosa et al.
ANNALS OF ONCOLOGY (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
Laurence Zitvogel et al.
SCIENCE (2018)
Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer
Florian Huemer et al.
Oncotarget (2018)
Balances: a New Perspective for Microbiome Analysis
J. Rivera-Pinto et al.
MSYSTEMS (2018)
Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment
Anna Louise Pouncey et al.
ECANCERMEDICALSCIENCE (2018)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
Arthur E. Frankel et al.
NEOPLASIA (2017)
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
N. Chaput et al.
ANNALS OF ONCOLOGY (2017)
DADA2: High-resolution sample inference from Illumina amplicon data
Benjamin J. Callahan et al.
NATURE METHODS (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vetizou et al.
SCIENCE (2015)
Ribosomal Database Project: data and tools for high throughput rRNA analysis
James R. Cole et al.
NUCLEIC ACIDS RESEARCH (2014)
Short-Term Effect of Antibiotics on Human Gut Microbiota
Suchita Panda et al.
PLOS ONE (2014)
Human gut microbiome viewed across age and geography
Tanya Yatsunenko et al.
NATURE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Interactions Between the Microbiota and the Immune System
Lora V. Hooper et al.
SCIENCE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Multivariate dispersion as a measure of beta diversity
MJ Anderson et al.
ECOLOGY LETTERS (2006)
分享论文
